These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 9138435)
1. Etiologic heterogeneity of the psychoses: is there a dopamine psychosis? Garver DL; Steinberg JL; McDermott BE; Yao JK; Ramberg JE; Lewis S; Kingsbury SJ Neuropsychopharmacology; 1997 Mar; 16(3):191-201. PubMed ID: 9138435 [TBL] [Abstract][Full Text] [Related]
2. A biomodal distribution of plasma HVA/MHPG in the psychoses. Ottong SE; Garver DL Psychiatry Res; 1997 Mar; 69(2-3):97-103. PubMed ID: 9109177 [TBL] [Abstract][Full Text] [Related]
3. Heterogeneity of response to antipsychotics from multiple disorders in the schizophrenia spectrum. Garver DL; Holcomb JA; Christensen JD J Clin Psychiatry; 2000 Dec; 61(12):964-72; quiz 973. PubMed ID: 11206608 [TBL] [Abstract][Full Text] [Related]
4. Effects of aripiprazole and the Taq1A polymorphism in the dopamine D2 receptor gene on the clinical response and plasma monoamine metabolites level during the acute phase of schizophrenia. Miura I; Takeuchi S; Katsumi A; Mori A; Kanno K; Yang Q; Mashiko H; Numata Y; Niwa S J Clin Psychopharmacol; 2012 Feb; 32(1):106-9. PubMed ID: 22198450 [TBL] [Abstract][Full Text] [Related]
5. Relationship between plasma homovanillic acid and outcome in patients with psychosis spectrum disorders. van de Kerkhof NW; Fekkes D; van der Heijden FM; Egger JI; Verhoeven WM Neuropsychobiology; 2015; 71(4):212-7. PubMed ID: 26279280 [TBL] [Abstract][Full Text] [Related]
13. Relationship of symptomatology, gender, and antipsychotic drug treatment with plasma homovanillic acid in schizophrenia. Zhang ZJ; Reynolds GP; Ramchand C; Peet M; Shah S Acta Pharmacol Sin; 2001 Jan; 22(1):76-80. PubMed ID: 11730567 [TBL] [Abstract][Full Text] [Related]
14. Plasma homovanillic acid in schizophrenics: supportive evidence for the two-subtype hypothesis. Chen TY; Lee CF; Lung FW; Lee TC; Lin WL; Hu WH; Yeh EK; Chang WH Taiwan Yi Xue Hui Za Zhi; 1989 Jun; 88(6):584-8. PubMed ID: 2571672 [TBL] [Abstract][Full Text] [Related]
15. Plasma homovanillic acid levels and therapeutic outcome in schizophrenics: comparisons of neuroleptic-naive first-episode patients and patients with disease exacerbation due to neuroleptic discontinuance. Akiyama K; Tsuchida K; Kanzaki A; Ujike H; Hamamura T; Kondo K; Mutoh S; Miyanagi K; Kuroda S; Otsuki S Biol Psychiatry; 1995 Nov; 38(10):639-48. PubMed ID: 8555375 [TBL] [Abstract][Full Text] [Related]
16. Sex differences in plasma homovanillic acid levels in schizophrenia and normal controls: relation to neuroleptic resistance. Sumiyoshi T; Hasegawa M; Jayathilake K; Meltzer HY Biol Psychiatry; 1997 Mar; 41(5):560-6. PubMed ID: 9046988 [TBL] [Abstract][Full Text] [Related]
17. Plasma homovanillic acid and family history of psychotic disorders in bipolar I patients. Zumárraga M; Dávila R; Basterreche N; Arrue A; Goienetxea B; González-Torres MA; Guimón J Pharmacol Res; 2009 Apr; 59(4):269-72. PubMed ID: 19162188 [TBL] [Abstract][Full Text] [Related]
18. Plasma catecholamine metabolites and early response to haloperidol. Bowers MB; Swigar ME; Jatlow PI; Goicoechea N J Clin Psychiatry; 1984 Jun; 45(6):248-51. PubMed ID: 6725216 [TBL] [Abstract][Full Text] [Related]